Lipocine Inc. Advances with Strategic Partnerships and Pipeline Developments Amid Financial Challenges
Lipocine Inc. navigates financial and strategic developments, including a revenue miss in Q1 2025, but remains focused on its pipeline and partnerships, including a Phase 3 study for LPCN 1154 and a license agreement in Brazil.
3 minutes to read